Exhibit 99.1 TriSalus Reports Q1 2024 Financial Results and Business Update · Reported revenues of $6.5 million in 1Q24, up 116$50 million of debt financing with OrbiMed to support TriNav® Infusion System growth initiatives · Announced the appointment of Liselotte Hyveled to the Board of Directors · Full year sales growth expected to exceed 50% · Conference call May 15 at 9:00 a.m. EDT DENVER – May 15, 2024 - TriSalus Life Sciences In ...